FDA approves Keytruda/Padcev combo in advanced urothelial cancer — Record growth in U.S. life sciences real estate footprint — Diabesity drugs and their free ‘contract sales force’ -- See more on our front page news http://bit.ly/w28kSd #fda #merck #astellas #urothelialcancer #realestate #diabetes #obesity #novonordisk #elililly #keytruda #lifesciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FdA #merck #astellas #urothelialcancer #realestate #diabetes #obesity #novonordisk #elililly #keytruda #lifesciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris — After several flops, Merck exec stands by aggressive Keytruda prostate cancer program—GSK vaccine R&D head touts consistency of RSV data-- See more on our front page news http://bit.ly/w28kSd #seagen #merck #mergersandacquisitions #keytruda #gsk #rsv #vaccines #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#seagen #merck #mergersandacquisitions #keytruda #gsk #RSV #vaccines #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’ — Merck's Keytruda gets a miss for prostate cancer and a hit for biliary tract cancer — Insulet reports personal-data leak of 29,000 insulin pump customers -- See more on our front page news http://bit.ly/w28kSd #venturecapital #digitization #merck #keytruda #prostatecancer #biliarytractcancer #insulet #medicaldevices #insulinpumps #dataleak #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#VentureCapital #digitization #merck #keytruda #ProstateCancer #biliarytractcancer #insulet #medicaldevices #insulinpumps #dataleak #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
“Personalized cancer vaccines are designed to prime the immune system so that a patient can generate a tailored antitumor response specific to their tumor mutation signature.” https://investors.modernatx.com/news/news-details/2022/Moderna-and-Merck-Announce-mRNA-4157V940-an-Investigational-Personalized-mRNA-Cancer-Vaccine-in-Combination-with-KEYTRUDAR-pembrolizumab-Met-Primary-Efficacy-Endpoint-in-Phase-2b-KEYNOTE-942-Trial/default.aspx
#pharmaceuticals #cancertreatment #antitumor #personalizedmedicine #moderna #merck #keytruda
#pharmaceuticals #cancertreatment #antitumor #personalizedmedicine #moderna #merck #keytruda
Phase 2b clinical trial from Moderna & Merck using an #mRNA #cancer #vaccine + #Keytruda for a #melanoma #vaccine for stage III & IV disease reducing the risk of recurrence or death by 44% compared to Keytruda alone. Serious treatment-related adverse events occurred in 14.4% of patients who received the combination arm compared to Keytruda alone.
Phase 3 trial is planned for 2023.
#mrna #cancer #Vaccine #keytruda #melanoma
Takeda wagers up to $6B on Nimbus’ TYK2 drug — Moderna, Merck mRNA cancer vaccine slashes melanoma recurrence in Keytruda combo trial — Covid vaccines averted 3 million deaths in U.S., according to new study -- See more on our front page news http://bit.ly/w28kSd #takeda #autoimmunedisease #mRNA #vaccines #Moderna #merck #keytruda #COVID #COVID19 #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#takeda #autoimmunedisease #mrna #vaccines #moderna #merck #keytruda #covid #covid19 #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma